FI883050A0 - Förfarande för framställning av terapeutiskt aktiva pyranoindolizinokinolinderivat - Google Patents
Förfarande för framställning av terapeutiskt aktiva pyranoindolizinokinolinderivatInfo
- Publication number
- FI883050A0 FI883050A0 FI883050A FI883050A FI883050A0 FI 883050 A0 FI883050 A0 FI 883050A0 FI 883050 A FI883050 A FI 883050A FI 883050 A FI883050 A FI 883050A FI 883050 A0 FI883050 A0 FI 883050A0
- Authority
- FI
- Finland
- Prior art keywords
- compound
- pyranoindolequinoquinoline
- derivatives
- preparation
- therapeutically active
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed systems contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D515/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D515/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Luminescent Compositions (AREA)
- Liquid Crystal Substances (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Lubricants (AREA)
- Fats And Perfumes (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP15699087 | 1987-06-24 | ||
JP15699087 | 1987-06-24 | ||
JP550388 | 1988-01-13 | ||
JP550388 | 1988-01-13 |
Publications (4)
Publication Number | Publication Date |
---|---|
FI883050A0 true FI883050A0 (sv) | 1988-06-23 |
FI883050A FI883050A (sv) | 1988-12-25 |
FI91872B FI91872B (sv) | 1994-05-13 |
FI91872C FI91872C (sv) | 1994-08-25 |
Family
ID=26339454
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI883050A FI91872C (sv) | 1987-06-24 | 1988-06-23 | Förfarande för framställning av terapeutiskt aktiva pyranoindolizinokinolinderivat |
Country Status (13)
Country | Link |
---|---|
US (2) | US4939255A (sv) |
EP (1) | EP0296597B1 (sv) |
KR (1) | KR960002853B1 (sv) |
AT (1) | ATE111913T1 (sv) |
AU (1) | AU610189B2 (sv) |
CA (1) | CA1304370C (sv) |
DE (1) | DE3851577T2 (sv) |
DK (1) | DK344488A (sv) |
ES (1) | ES2064329T3 (sv) |
FI (1) | FI91872C (sv) |
IE (1) | IE61281B1 (sv) |
NO (1) | NO167738C (sv) |
PH (1) | PH27557A (sv) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4939255A (en) * | 1987-06-24 | 1990-07-03 | Daiichi Pharmaceutical Co., Ltd. | Hexa-cyclic camptothecin derivatives |
US5552154A (en) * | 1989-11-06 | 1996-09-03 | The Stehlin Foundation For Cancer Research | Method for treating cancer with water-insoluble s-camptothecin of the closed lactone ring form and derivatives thereof |
JP3008226B2 (ja) * | 1991-01-16 | 2000-02-14 | 第一製薬株式会社 | 六環性化合物 |
US5637770A (en) * | 1991-01-16 | 1997-06-10 | Daiichi Pharmaceutical Co., Ltd. | Hexa-cyclic compound |
US6407115B1 (en) * | 1991-01-16 | 2002-06-18 | Daiichi Pharmaceutical Co., Ltd. | Hexa-cyclic compound |
US6080751A (en) * | 1992-01-14 | 2000-06-27 | The Stehlin Foundation For Cancer Research | Method for treating pancreatic cancer in humans with water-insoluble S-camptothecin of the closed lactone ring form and derivatives thereof |
US5446047A (en) * | 1992-07-23 | 1995-08-29 | Sloan-Kettering Institute For Cancer Research | Camptothecin analogues |
US5391745A (en) * | 1992-07-23 | 1995-02-21 | Sloan-Kettering Institute For Cancer Research | Methods of preparation of camptothecin analogs |
US6504029B1 (en) * | 1995-04-10 | 2003-01-07 | Daiichi Pharmaceutical Co., Ltd. | Condensed-hexacyclic compounds and a process therefor |
US5663177A (en) * | 1995-05-31 | 1997-09-02 | Smithkline Beecham Corporation | Water soluble camptothecin analogs |
US5670500A (en) * | 1995-05-31 | 1997-09-23 | Smithkline Beecham Corporation | Water soluble camptothecin analogs |
EP0835303A4 (en) * | 1995-06-07 | 2000-09-13 | Univ Jefferson | ANTIFUNGAL AGENTS AND THEIR IDENTIFICATION AND UTILIZATION METHODS |
SG50747A1 (en) * | 1995-08-02 | 1998-07-20 | Tanabe Seiyaku Co | Comptothecin derivatives |
TW464652B (en) | 1996-10-30 | 2001-11-21 | Tanabe Seiyaku Co | S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof |
KR19980076076A (ko) * | 1997-04-04 | 1998-11-16 | 유현식 | 전선용 발포성 수지조성물 |
US6046209A (en) * | 1997-05-27 | 2000-04-04 | Smithkline Beecham Corporation | Water soluble camptothecin analogs |
IN189180B (sv) | 1997-07-09 | 2003-01-04 | Chong Kun Dang Corp | |
JP4094710B2 (ja) | 1997-11-06 | 2008-06-04 | 株式会社ヤクルト本社 | 新規なカンプトテシン誘導体 |
EP2289549A3 (en) | 1999-10-01 | 2011-06-15 | Immunogen, Inc. | Immunoconjugates for treating cancer |
FR2801309B1 (fr) * | 1999-11-18 | 2002-01-04 | Adir | Nouveaux composes analogues de la camptothecine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
RU2299212C2 (ru) | 2001-11-30 | 2007-05-20 | Чугаи Сейяку Кабусики Кайся | Гексациклические соединения, фармацевтическая композиция, содержащая их и их применение в качестве противоопухолевых средств, способ получения гексациклических соединений |
US7563810B2 (en) | 2002-11-06 | 2009-07-21 | Celgene Corporation | Methods of using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myeloproliferative diseases |
US8034831B2 (en) | 2002-11-06 | 2011-10-11 | Celgene Corporation | Methods for the treatment and management of myeloproliferative diseases using 4-(amino)-2-(2,6-Dioxo(3-piperidyl)-isoindoline-1,3-dione in combination with other therapies |
CN1777611A (zh) * | 2003-02-21 | 2006-05-24 | 中外制药株式会社 | 制备六环喜树碱衍生物的方法 |
CN1964979B (zh) | 2004-04-09 | 2011-07-27 | 中外制药株式会社 | 新颖的水溶性前药 |
TW200744603A (en) | 2005-08-22 | 2007-12-16 | Chugai Pharmaceutical Co Ltd | Novel anticancer concomitant drug |
CN102060713A (zh) * | 2010-12-09 | 2011-05-18 | 中华人民共和国嘉兴出入境检验检疫局 | 用于检测偶氮类染料的芳香胺半抗原及其制备方法 |
PT3946464T (pt) | 2019-03-29 | 2022-11-16 | Medimmune Ltd | Compostos e seus conjugados |
TW202140076A (zh) | 2020-01-22 | 2021-11-01 | 英商梅迪繆思有限公司 | 化合物及其軛合物 |
MX2022009052A (es) | 2020-01-22 | 2022-08-15 | Medimmune Ltd | Compuestos y conjugados de estos. |
US11806405B1 (en) | 2021-07-19 | 2023-11-07 | Zeno Management, Inc. | Immunoconjugates and methods |
WO2023180484A1 (en) | 2022-03-23 | 2023-09-28 | Synaffix B.V. | Antibody-conjugates for targeting of tumours expressing ptk7 |
WO2023180485A1 (en) | 2022-03-23 | 2023-09-28 | Synaffix B.V. | Antibody-conjugates for targeting of tumours expressing trop-2 |
WO2023180489A1 (en) | 2022-03-23 | 2023-09-28 | Synaffix B.V. | Antibody-conjugates for targeting of tumours expressing carcinoembyronic antigen |
WO2023180490A1 (en) | 2022-03-23 | 2023-09-28 | Synaffix B.V. | Antibody-conjugates for targeting of tumours expressing nectin-4 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US32518A (en) * | 1861-06-11 | Improvement in city railroads | ||
JPS51288A (ja) * | 1974-06-18 | 1976-01-05 | Tamura Seisakusho Kk | Hanshakyoshinhoshasochi |
US4399282A (en) * | 1979-07-10 | 1983-08-16 | Kabushiki Kaisha Yakult Honsha | Camptothecin derivatives |
US4399276A (en) * | 1981-01-09 | 1983-08-16 | Kabushiki Kaisha Yakult Honsha | 7-Substituted camptothecin derivatives |
JPS5839685A (ja) * | 1981-09-04 | 1983-03-08 | Yakult Honsha Co Ltd | 新規なカンプトテシン誘導体及びその製造法 |
US4473692A (en) * | 1981-09-04 | 1984-09-25 | Kabushiki Kaisha Yakult Honsha | Camptothecin derivatives and process for preparing same |
JPS58154582A (ja) * | 1982-03-10 | 1983-09-14 | Yakult Honsha Co Ltd | 新規なカンプトテシン誘導体およびその製造法 |
JPS6019790A (ja) * | 1983-07-14 | 1985-01-31 | Yakult Honsha Co Ltd | 新規なカンプトテシン誘導体 |
DE3682874D1 (de) * | 1985-10-21 | 1992-01-23 | Daiichi Seiyaku Co | Pyranoindolizinderivate und verfahren zu ihrer herstellung. |
US4939255A (en) * | 1987-06-24 | 1990-07-03 | Daiichi Pharmaceutical Co., Ltd. | Hexa-cyclic camptothecin derivatives |
US5004758A (en) * | 1987-12-01 | 1991-04-02 | Smithkline Beecham Corporation | Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells |
JPH0615547B2 (ja) * | 1988-01-20 | 1994-03-02 | 株式会社ヤクルト本社 | 新規なカンプトテシン誘導体 |
-
1988
- 1988-06-16 US US07/207,718 patent/US4939255A/en not_active Expired - Fee Related
- 1988-06-20 IE IE186088A patent/IE61281B1/en not_active IP Right Cessation
- 1988-06-21 CA CA000569969A patent/CA1304370C/en not_active Expired - Lifetime
- 1988-06-23 NO NO882785A patent/NO167738C/no unknown
- 1988-06-23 ES ES88110044T patent/ES2064329T3/es not_active Expired - Lifetime
- 1988-06-23 DE DE3851577T patent/DE3851577T2/de not_active Expired - Fee Related
- 1988-06-23 AT AT88110044T patent/ATE111913T1/de not_active IP Right Cessation
- 1988-06-23 DK DK344488A patent/DK344488A/da not_active Application Discontinuation
- 1988-06-23 FI FI883050A patent/FI91872C/sv not_active IP Right Cessation
- 1988-06-23 EP EP88110044A patent/EP0296597B1/en not_active Expired - Lifetime
- 1988-06-24 KR KR1019880007643A patent/KR960002853B1/ko not_active IP Right Cessation
- 1988-06-24 AU AU18349/88A patent/AU610189B2/en not_active Ceased
- 1988-07-22 PH PH37104A patent/PH27557A/en unknown
-
1989
- 1989-12-27 US US07/457,921 patent/US5061795A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
FI91872B (sv) | 1994-05-13 |
DE3851577T2 (de) | 1995-04-27 |
KR960002853B1 (ko) | 1996-02-27 |
IE61281B1 (en) | 1994-10-19 |
NO882785L (no) | 1988-12-27 |
NO882785D0 (no) | 1988-06-23 |
EP0296597A2 (en) | 1988-12-28 |
US4939255A (en) | 1990-07-03 |
FI883050A (sv) | 1988-12-25 |
EP0296597A3 (en) | 1991-07-31 |
IE881860L (en) | 1988-12-24 |
FI91872C (sv) | 1994-08-25 |
US5061795A (en) | 1991-10-29 |
DK344488D0 (da) | 1988-06-23 |
AU610189B2 (en) | 1991-05-16 |
AU1834988A (en) | 1989-01-05 |
NO167738B (no) | 1991-08-26 |
ATE111913T1 (de) | 1994-10-15 |
EP0296597B1 (en) | 1994-09-21 |
CA1304370C (en) | 1992-06-30 |
NO167738C (no) | 1991-12-04 |
DK344488A (da) | 1989-02-24 |
PH27557A (en) | 1993-08-18 |
ES2064329T3 (es) | 1995-02-01 |
DE3851577D1 (de) | 1994-10-27 |
KR890000489A (ko) | 1989-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI883050A0 (sv) | Förfarande för framställning av terapeutiskt aktiva pyranoindolizinokinolinderivat | |
FI103047B (sv) | Förfarande för framställning av nya terapeutiskt användbara benso£de|p yrano£3',4':6,7|indolitsino£1,2-b|kinolinderivat | |
IS1564B (is) | Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar | |
NO172344C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte flavonoidforbindelser og salter | |
NO162965C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive alfa-(2-okso-2,4,5,6,7,7a-heksahydrotieno-(3,2-c)-5-pyridyl)-fenyl-eddiksyre-derivater. | |
DE3764724D1 (de) | 2-phenylbenzoxepin-derivat. | |
ES2063186T3 (es) | Derivados ftalinida, composicion farmaceutica y uso. | |
AU1302388A (en) | Method of treating anxiety with tetrahydrobenz(c,d)indole-6- carboxamides | |
FI871087A (sv) | Förfarande för framställning av terapeutiskt användbara 1,2,3,4-tetrahydro-3-karbamoyl-2-tioxo/oxo-5-pyrimidinkarboxylsyraderivat | |
NO180269C (no) | Analogifremgangsmåte for fremstilling av terapeutisk akive aminoketonderivater | |
NO172495C (no) | Fremgangsmaate for fremstilling av terapeutisk aktive, ikke-mettede aminosyreforbindelser | |
FI860816A (sv) | Förfarande för framställning av terapeutiskt användbara polyprenylföreningar | |
HUT46214A (en) | Process for producing medical preparation suitable for treatment of peptic ulcer | |
NO303825B1 (no) | Imidazolyl-substituerte cykloheksanderivater, legemidler inneholdende derivatene, anvendelse av derivatene for fremstilling av legemidler samt mellomprodukter for fremstilling av derivatene | |
HU886315D0 (en) | Process for the production of pharmaceutical preparations for curing hyperlipaemia, containing oxoquinazoline derivatives as active agents | |
NO890261D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridin-derivater. | |
IE883116L (en) | Preparation of antiviral and antitumour pharmaceutical and¹veterinary composition | |
DE3379224D1 (en) | 3-methoxy-n-methylmorphinane : theophyllinacetic acid (1:2) complex, process for preparing the same and said complex for therapeutical use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BB | Publication of examined application | ||
MM | Patent lapsed | ||
MM | Patent lapsed |
Owner name: DAIICHI SEIYAKU CO., LTD. Owner name: KABUSHIKI KAISHA YAKULT HONSHA |